Edge AI
Summary
Intel has expanded its edge AI portfolio with new processors and a software suite designed for healthcare and life sciences. The Intel® Core™ Series 2 processors offer deterministic, real-time compute for medical devices and industrial healthcare systems, featuring up to 12 P-cores and 1.5x higher multi-threaded performance than the prior generation. The Intel® Core™ Ultra Series 3 processors integrate AI acceleration for generative and agentic AI workloads, providing up to 180 platform TOPS across CPU, GPU, and NPU, and demonstrating up to 1.9x faster LLM performance compared to NVIDIA Jetson Orin AGX 64GB. Additionally, the new Health and Life Sciences AI Suite provides an industry-optimized software stack built on open-source foundations like OpenVINO™ toolkit, accelerating multimodal patient monitoring, diagnostics, and clinical intelligence at the edge. These solutions aim to address the critical need for low-latency, real-time processing and data locality in clinical settings.
Key takeaway
For AI Architects and AI Engineers designing solutions for healthcare, Intel's new Core Series 2 and Ultra Series 3 processors, coupled with the Health and Life Sciences AI Suite, offer a compelling platform. You should evaluate these integrated edge AI solutions to meet stringent real-time, low-latency, and data locality requirements, potentially reducing TCO by up to 67% compared to discrete GPU alternatives and accelerating time to production for critical clinical applications.
Key insights
Edge computing with integrated AI acceleration is crucial for real-time, deterministic healthcare applications.
Principles
- Deterministic performance is non-negotiable for medical devices.
- AI workloads in healthcare belong at the edge for optimal latency and data locality.
- Open systems and ecosystems reduce deployment risk in regulated industries.
Method
Intel's approach combines specialized processors (Core Series 2 for real-time, Core Ultra Series 3 for integrated AI) with an optimized software stack (Health and Life Sciences AI Suite) to accelerate edge AI deployment in healthcare.
In practice
- Utilize Intel Core Ultra Series 3 for combined real-time control and AI acceleration.
- Deploy OpenVINO™ toolkit for AI optimization across diverse hardware.
- Consider pre-validated Intel AI Edge Systems for faster time to market.
Topics
- Edge AI in Healthcare
- Intel Edge AI Processors
- Deterministic Computing
- Generative AI Acceleration
- OpenVINO Toolkit
Code references
Best for: AI Architect, AI Engineer, CTO, Machine Learning Engineer, MLOps Engineer, AI Product Manager
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Artificial Intelligence (AI) articles.